VALPROATE Drug Patent Profile
✉ Email this page to a colleague
When do Valproate patents expire, and when can generic versions of Valproate launch?
Valproate is a drug marketed by Fresenius Kabi Usa, Hikma Farmaceutica, Pharmobedient, and Sagent. and is included in four NDAs.
The generic ingredient in VALPROATE is valproate sodium. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the valproate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Valproate
A generic version of VALPROATE was approved as valproate sodium by SAGENT on November 14th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VALPROATE?
- What are the global sales for VALPROATE?
- What is Average Wholesale Price for VALPROATE?
Summary for VALPROATE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for VALPROATE |
| DailyMed Link: | VALPROATE at DailyMed |
US Patents and Regulatory Information for VALPROATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | VALPROATE SODIUM | valproate sodium | INJECTABLE;INJECTION | 076539-001 | Jun 26, 2003 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sagent | VALPROATE SODIUM | valproate sodium | INJECTABLE;INJECTION | 076295-001 | Nov 14, 2002 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma Farmaceutica | VALPROATE SODIUM | valproate sodium | INJECTABLE;INJECTION | 078523-001 | Feb 17, 2010 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | VALPROATE SODIUM | valproate sodium | INJECTABLE;INJECTION | 208120-001 | Dec 22, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
